Our
perception of biomarkers tends to be limited to the realm of measures that
provide information about disease and drug activity. In fact, biomarkers can provide a means to
assess additional biological processes relevant to patient well being such as
anxiety and pain. In paper published in
the September 13th issue of PLoS One (link),
a team of the Department of Anesthesia, Stanford University describes a new functional
MRI-based (fMRI) biomarker for the identification of pain. Because the sensation of pain can be
subjective and can occur in the absence of detectable injury, the standard for
assessing pain is based on patient self report.
While this traditional measure is readily assessable, it does not
differentiate between the sensory and the psychological components of pain
perception. In addition, patient self
reported pain assessment is impossible in individuals who are not able to
communicate. Therefore, development of
an objective biomarker of pain is of great interest to the medical
community.
The
team at Stanford performed a pilot study involving 24 individuals who were
monitored by fMRI while being subjected to painful and non-painful thermal
stimuli. Using the results from the first
8 volunteers, the team used Support Vector Machine learning to develop a predictive
model that then validated on the remaining 16 individual volunteers. In this setting, the model accurately
identified the type of stimulus with 81 % accuracy.
While
the size of this study is not sufficient to draw definitive conclusions, it is
tempting to speculate that the future of pain management in patients who are
unable to communicate may improve dramatically
Thierry
Sornasse for Integrated Biomarker Strategy
"future of pain management in patients who are unable to communicate may improve dramatically"---- lets hope so!!
ReplyDeletethanks for the article, well written!!
underdtanding Pain imaging